{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:28Z","timestamp":1762507468707},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.tcm.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T04:11:56Z","timestamp":1532059916000},"page":"48-49","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Editorial Commentary: Prevention and treatment of atrial fibrillation: Is hyperuricemia the next target?"],"prefix":"10.1016","volume":"29","author":[{"given":"Eric","family":"Black-Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Daubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tcm.2018.07.006_bib0001","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2018.07.006_bib0002","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.tcm.2018.07.006_bib0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"19","key":"10.1016\/j.tcm.2018.07.006_bib0004","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: A randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.tcm.2018.07.006_bib0005","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.07.006_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2018.02.013","article-title":"Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis","volume":"46","author":"Deng","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.tcm.2018.07.006_bib0007","article-title":"Gout and arrhythmias: In search for causation beyond association","author":"Giannopoulos","year":"2018","journal-title":"Trends Cardiovasc. Med"},{"issue":"4","key":"10.1016\/j.tcm.2018.07.006_bib0008","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1016\/j.ijcard.2013.06.067","article-title":"The association between hyperuricemia, left atrial size and new-onset atrial fibrillation","volume":"168","author":"Chao","year":"2013","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2018.07.006_bib0009","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.amjcard.2011.06.043","article-title":"Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"108","author":"Tamariz","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2018.07.006_bib0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/annrheumdis-2017-212189","article-title":"Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden","volume":"77","author":"Bengtsson","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.tcm.2018.07.006_bib0011","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1756-185X.12820","article-title":"Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"20","author":"Ungprasert","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.tcm.2018.07.006_bib0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/annrheumdis-2015-209008","article-title":"Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data","volume":"76","author":"Singh","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.tcm.2018.07.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008807","article-title":"Xanthine oxidase inhibitor allopurinol prevents oxidative stress-mediated atrial remodeling in alloxan-induced diabetes mellitus rabbits","volume":"7","author":"Yang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.tcm.2018.07.006_bib0014","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1540-8167.2012.02356.x","article-title":"Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction","volume":"23","author":"Sakabe","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.tcm.2018.07.006_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.40.3.245","article-title":"Acute adverse reactions attributed to allopurinol in hospitalised patients","volume":"40","author":"McInnes","year":"1981","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.tcm.2018.07.006_bib0016","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure. Validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.tcm.2018.07.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.01.013","article-title":"Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.tcm.2018.07.006_bib0018","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2018.07.006_bib0019","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circulation Heart Fail"},{"issue":"3","key":"10.1016\/j.tcm.2018.07.006_bib0020","first-page":"602","article-title":"The impact of atrial fibrillation ablation on quality of life","volume":"5","author":"Pontoppidan","year":"2012","journal-title":"J Atr Fibrillation"},{"issue":"12","key":"10.1016\/j.tcm.2018.07.006_bib0021","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/europace\/euu198","article-title":"Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation","volume":"16","author":"Canpolat","year":"2014","journal-title":"Europace"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017381830135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017381830135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:25:55Z","timestamp":1545420355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017381830135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S105017381830135X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2018.07.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial Commentary: Prevention and treatment of atrial fibrillation: Is hyperuricemia the next target?","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}